vs
Side-by-side financial comparison of Donnelley Financial Solutions, Inc. (DFIN) and HAEMONETICS CORP (HAE). Click either name above to swap in a different company.
HAEMONETICS CORP is the larger business by last-quarter revenue ($339.0M vs $172.5M, roughly 2.0× Donnelley Financial Solutions, Inc.). HAEMONETICS CORP runs the higher net margin — 13.2% vs 3.6%, a 9.6% gap on every dollar of revenue. On growth, Donnelley Financial Solutions, Inc. posted the faster year-over-year revenue change (10.4% vs -2.7%). HAEMONETICS CORP produced more free cash flow last quarter ($87.2M vs $47.9M). Over the past eight quarters, HAEMONETICS CORP's revenue compounded faster (0.4% CAGR vs -7.9%).
Donnelley Financial Solutions (DFIN) is a financial compliance company based in Chicago, Illinois, United States. The company provides software as a service (SaaS) products, software-enabled services (SeS), print, and compliance services related to US Securities and Exchange Commission regulations to companies in capital and investment markets.
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
DFIN vs HAE — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $172.5M | $339.0M |
| Net Profit | $6.2M | $44.7M |
| Gross Margin | — | 59.7% |
| Operating Margin | 8.3% | 19.9% |
| Net Margin | 3.6% | 13.2% |
| Revenue YoY | 10.4% | -2.7% |
| Net Profit YoY | -1.6% | 19.3% |
| EPS (diluted) | $0.31 | $0.95 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $172.5M | $339.0M | ||
| Q3 25 | $175.3M | $327.3M | ||
| Q2 25 | $218.1M | $321.4M | ||
| Q1 25 | $201.1M | $330.6M | ||
| Q4 24 | $156.3M | $348.5M | ||
| Q3 24 | $179.5M | $345.5M | ||
| Q2 24 | $242.7M | $336.2M | ||
| Q1 24 | $203.4M | — |
| Q4 25 | $6.2M | $44.7M | ||
| Q3 25 | $-40.9M | $38.7M | ||
| Q2 25 | $36.1M | $34.0M | ||
| Q1 25 | $31.0M | $58.0M | ||
| Q4 24 | $6.3M | $37.5M | ||
| Q3 24 | $8.7M | $33.8M | ||
| Q2 24 | $44.1M | $38.4M | ||
| Q1 24 | $33.3M | — |
| Q4 25 | — | 59.7% | ||
| Q3 25 | — | 59.5% | ||
| Q2 25 | — | 59.8% | ||
| Q1 25 | — | 58.4% | ||
| Q4 24 | — | 55.5% | ||
| Q3 24 | — | 54.2% | ||
| Q2 24 | — | 52.0% | ||
| Q1 24 | — | — |
| Q4 25 | 8.3% | 19.9% | ||
| Q3 25 | 16.1% | 17.9% | ||
| Q2 25 | 24.2% | 16.8% | ||
| Q1 25 | 22.8% | 21.6% | ||
| Q4 24 | 6.0% | 16.9% | ||
| Q3 24 | 10.1% | 15.0% | ||
| Q2 24 | 26.6% | 11.8% | ||
| Q1 24 | 21.9% | — |
| Q4 25 | 3.6% | 13.2% | ||
| Q3 25 | -23.3% | 11.8% | ||
| Q2 25 | 16.6% | 10.6% | ||
| Q1 25 | 15.4% | 17.5% | ||
| Q4 24 | 4.0% | 10.8% | ||
| Q3 24 | 4.8% | 9.8% | ||
| Q2 24 | 18.2% | 11.4% | ||
| Q1 24 | 16.4% | — |
| Q4 25 | $0.31 | $0.95 | ||
| Q3 25 | $-1.49 | $0.81 | ||
| Q2 25 | $1.28 | $0.70 | ||
| Q1 25 | $1.05 | $1.17 | ||
| Q4 24 | $0.21 | $0.74 | ||
| Q3 24 | $0.29 | $0.66 | ||
| Q2 24 | $1.47 | $0.74 | ||
| Q1 24 | $1.09 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $24.5M | $363.4M |
| Total DebtLower is stronger | $171.3M | $1.2B |
| Stockholders' EquityBook value | $379.2M | $911.5M |
| Total Assets | $800.4M | $2.5B |
| Debt / EquityLower = less leverage | 0.45× | 1.34× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $24.5M | $363.4M | ||
| Q3 25 | $22.7M | $296.4M | ||
| Q2 25 | $33.8M | $292.9M | ||
| Q1 25 | $16.2M | $306.8M | ||
| Q4 24 | $57.3M | $320.8M | ||
| Q3 24 | $33.6M | $299.3M | ||
| Q2 24 | $35.0M | $344.4M | ||
| Q1 24 | $43.7M | — |
| Q4 25 | $171.3M | $1.2B | ||
| Q3 25 | $154.7M | $1.2B | ||
| Q2 25 | $190.1M | $1.2B | ||
| Q1 25 | $189.5M | $1.2B | ||
| Q4 24 | $124.7M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $379.2M | $911.5M | ||
| Q3 25 | $423.1M | $849.2M | ||
| Q2 25 | $432.1M | $882.3M | ||
| Q1 25 | $419.9M | $820.8M | ||
| Q4 24 | $436.1M | $906.9M | ||
| Q3 24 | $444.5M | $878.9M | ||
| Q2 24 | $441.5M | $905.4M | ||
| Q1 24 | $408.9M | — |
| Q4 25 | $800.4M | $2.5B | ||
| Q3 25 | $816.3M | $2.4B | ||
| Q2 25 | $874.7M | $2.5B | ||
| Q1 25 | $852.8M | $2.5B | ||
| Q4 24 | $841.6M | $2.5B | ||
| Q3 24 | $843.6M | $2.5B | ||
| Q2 24 | $882.9M | $2.5B | ||
| Q1 24 | $867.8M | — |
| Q4 25 | 0.45× | 1.34× | ||
| Q3 25 | 0.37× | 1.44× | ||
| Q2 25 | 0.44× | 1.39× | ||
| Q1 25 | 0.45× | 1.49× | ||
| Q4 24 | 0.29× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $59.8M | $93.6M |
| Free Cash FlowOCF − Capex | $47.9M | $87.2M |
| FCF MarginFCF / Revenue | 27.8% | 25.7% |
| Capex IntensityCapex / Revenue | 6.9% | 1.9% |
| Cash ConversionOCF / Net Profit | 9.65× | 2.09× |
| TTM Free Cash FlowTrailing 4 quarters | $107.8M | $308.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $59.8M | $93.6M | ||
| Q3 25 | $74.4M | $111.3M | ||
| Q2 25 | $68.4M | $17.4M | ||
| Q1 25 | $-37.7M | $116.6M | ||
| Q4 24 | $56.4M | $43.8M | ||
| Q3 24 | $86.4M | $48.8M | ||
| Q2 24 | $56.2M | $-27.4M | ||
| Q1 24 | $-27.9M | — |
| Q4 25 | $47.9M | $87.2M | ||
| Q3 25 | $59.2M | $106.3M | ||
| Q2 25 | $51.7M | $13.6M | ||
| Q1 25 | $-51.0M | $100.9M | ||
| Q4 24 | $41.3M | $35.2M | ||
| Q3 24 | $67.3M | $39.4M | ||
| Q2 24 | $36.8M | $-33.1M | ||
| Q1 24 | $-40.2M | — |
| Q4 25 | 27.8% | 25.7% | ||
| Q3 25 | 33.8% | 32.5% | ||
| Q2 25 | 23.7% | 4.2% | ||
| Q1 25 | -25.4% | 30.5% | ||
| Q4 24 | 26.4% | 10.1% | ||
| Q3 24 | 37.5% | 11.4% | ||
| Q2 24 | 15.2% | -9.8% | ||
| Q1 24 | -19.8% | — |
| Q4 25 | 6.9% | 1.9% | ||
| Q3 25 | 8.7% | 1.5% | ||
| Q2 25 | 7.7% | 1.2% | ||
| Q1 25 | 6.6% | 4.7% | ||
| Q4 24 | 9.7% | 2.5% | ||
| Q3 24 | 10.6% | 2.7% | ||
| Q2 24 | 8.0% | 1.7% | ||
| Q1 24 | 6.0% | — |
| Q4 25 | 9.65× | 2.09× | ||
| Q3 25 | — | 2.88× | ||
| Q2 25 | 1.89× | 0.51× | ||
| Q1 25 | -1.22× | 2.01× | ||
| Q4 24 | 8.95× | 1.17× | ||
| Q3 24 | 9.93× | 1.44× | ||
| Q2 24 | 1.27× | -0.71× | ||
| Q1 24 | -0.84× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DFIN
| Technology Service | $68.0M | 39% |
| Capital Markets Compliance And Communications Management | $61.6M | 36% |
| Investment Companies Software Solutions | $30.9M | 18% |
| Print And Distribution Service | $13.6M | 8% |
HAE
| Hospital | $143.5M | 42% |
| Plasma Productsand Services | $138.9M | 41% |
| Blood Center Productsand Services | $56.6M | 17% |
